A detailed history of Adalta Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Adalta Capital Management LLC holds 1,385 shares of LLY stock, worth $1.15 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
1,385
Previous 1,185 16.88%
Holding current value
$1.15 Million
Previous $921,000 36.05%
% of portfolio
0.75%
Previous 0.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $144,974 - $181,808
200 Added 16.88%
1,385 $1.25 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $103,635 - $138,649
175 Added 17.33%
1,185 $921,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $191,694 - $225,982
365 Added 56.59%
1,010 $588,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $69,552 - $95,888
160 Added 32.99%
645 $346,000
Q2 2023

Aug 23, 2023

BUY
$350.74 - $468.98 $170,108 - $227,455
485 New
485 $227,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Adalta Capital Management LLC Portfolio

Follow Adalta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adalta Capital Management LLC with notifications on news.